메뉴 건너뛰기




Volumn 104, Issue 1, 2009, Pages 29-35

Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein Cholesterol Levels With Rosuvastatin 40 mg Daily (from the ASTEROID Study)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATINE KINASE; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MUSCLE ENZYME; ROSUVASTATIN;

EID: 67649342170     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.02.040     Document Type: Article
Times cited : (22)

References (23)
  • 1
    • 26244432388 scopus 로고    scopus 로고
    • Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    • Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., Kirby A., Sourjina T., Peto R., Collins R., and Simes R. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
    • (2005) Lancet , vol.366 , pp. 1267-1278
    • Baigent, C.1    Keech, A.2    Kearney, P.M.3    Blackwell, L.4    Buck, G.5    Pollicino, C.6    Kirby, A.7    Sourjina, T.8    Peto, R.9    Collins, R.10    Simes, R.11
  • 5
    • 0026681128 scopus 로고
    • Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial
    • Neaton J.D., Blackburn H., Jacobs D., Kuller L., Lee D.J., Sherwin R., Shih J., Stamler J., and Wentworth D. Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 152 (1992) 1490-1500
    • (1992) Arch Intern Med , vol.152 , pp. 1490-1500
    • Neaton, J.D.1    Blackburn, H.2    Jacobs, D.3    Kuller, L.4    Lee, D.J.5    Sherwin, R.6    Shih, J.7    Stamler, J.8    Wentworth, D.9
  • 6
    • 0025828611 scopus 로고
    • Serum cholesterol and mortality among Japanese-American men
    • Honolulu (Hawaii) Heart Program
    • Stemmermann G.N., Chyou P.H., Kagan A., Nomura A.M., Yano K., and Honolulu (Hawaii) Heart Program. Serum cholesterol and mortality among Japanese-American men. Arch Intern Med 151 (1991) 969-972
    • (1991) Arch Intern Med , vol.151 , pp. 969-972
    • Stemmermann, G.N.1    Chyou, P.H.2    Kagan, A.3    Nomura, A.M.4    Yano, K.5
  • 7
    • 34547970751 scopus 로고    scopus 로고
    • Safety and efficacy of atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease (a post hoc analysis of the Treating to New Targets [TNT] study)
    • LaRosa J.C., Grundy S.M., Kastelein J.J., Kostis J.B., and Greten H. Safety and efficacy of atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease (a post hoc analysis of the Treating to New Targets [TNT] study). Am J Cardiol 100 (2007) 747-752
    • (2007) Am J Cardiol , vol.100 , pp. 747-752
    • LaRosa, J.C.1    Grundy, S.M.2    Kastelein, J.J.3    Kostis, J.B.4    Greten, H.5
  • 8
    • 26844468578 scopus 로고    scopus 로고
    • Can low-density lipoprotein be too low?. The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy
    • Wiviott S.D., Cannon C.P., Morrow D.A., Ray K.K., Pfeffer M.A., and Braunwald E. Can low-density lipoprotein be too low?. The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. J Am Coll Cardiol 46 (2005) 1411-1416
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1411-1416
    • Wiviott, S.D.1    Cannon, C.P.2    Morrow, D.A.3    Ray, K.K.4    Pfeffer, M.A.5    Braunwald, E.6
  • 11
    • 34250618645 scopus 로고    scopus 로고
    • Safety and efficacy of very low LDL-C levels: a post-hoc analysis of the TNT study
    • LaRosa J.C., SM G., Kastelein J.J., and JB K. Safety and efficacy of very low LDL-C levels: a post-hoc analysis of the TNT study. Circulation 112 (2005) 662-663
    • (2005) Circulation , vol.112 , pp. 662-663
    • LaRosa, J.C.1    SM, G.2    Kastelein, J.J.3    JB, K.4
  • 12
    • 0037226969 scopus 로고    scopus 로고
    • Effects of statins in reducing thrombotic risk and modulating plaque vulnerability
    • Libby P., and Aikawa M. Effects of statins in reducing thrombotic risk and modulating plaque vulnerability. Clin Cardiol 26 (2003) 11-14
    • (2003) Clin Cardiol , vol.26 , pp. 11-14
    • Libby, P.1    Aikawa, M.2
  • 15
    • 36249022736 scopus 로고    scopus 로고
    • Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein
    • Ridker P.M., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J., Khurmi N.S., Koenig W., Libby P., Lorenzatti A.J., Nordestgaard B.G., Shepherd J., Willerson J.T., and Glynn R.J. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. Am J Cardiol 100 (2007) 1659-1664
    • (2007) Am J Cardiol , vol.100 , pp. 1659-1664
    • Ridker, P.M.1    Fonseca, F.A.2    Genest, J.3    Gotto, A.M.4    Kastelein, J.J.5    Khurmi, N.S.6    Koenig, W.7    Libby, P.8    Lorenzatti, A.J.9    Nordestgaard, B.G.10    Shepherd, J.11    Willerson, J.T.12    Glynn, R.J.13
  • 18
    • 0041526376 scopus 로고    scopus 로고
    • Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients
    • Newman C.B., Palmer G., Silbershatz H., and Szarek M. Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients. Am J Cardiol 92 (2003) 670-676
    • (2003) Am J Cardiol , vol.92 , pp. 670-676
    • Newman, C.B.1    Palmer, G.2    Silbershatz, H.3    Szarek, M.4
  • 20
    • 34248223741 scopus 로고    scopus 로고
    • Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program
    • Shepherd J., Vidt D.G., Miller E., Harris S., and Blasetto J. Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program. Cardiology 107 (2007) 433-443
    • (2007) Cardiology , vol.107 , pp. 433-443
    • Shepherd, J.1    Vidt, D.G.2    Miller, E.3    Harris, S.4    Blasetto, J.5
  • 23
    • 43449113279 scopus 로고    scopus 로고
    • Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden
    • Ballantyne C.M., Raichlen J.S., Nicholls S.J., Erbel R., Tardif J.C., Brener S.J., Cain V.A., and Nissen S.E. Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation 117 (2008) 2458-2466
    • (2008) Circulation , vol.117 , pp. 2458-2466
    • Ballantyne, C.M.1    Raichlen, J.S.2    Nicholls, S.J.3    Erbel, R.4    Tardif, J.C.5    Brener, S.J.6    Cain, V.A.7    Nissen, S.E.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.